Positive Data For Threshold-Suspend Feature Of Medtronic Insulin Pump
This article was originally published in The Gray Sheet
Executive Summary
Medtronic says the ability to automatically suspend insulin delivery when glucose levels drop to a preset threshold is an important technological milestone en route to a fully automated artificial pancreas.
You may also be interested in...
Medtronic Sees Long-Awaited Approval Of MiniMed 530G As A Big Step In Artificial Pancreas “Journey”
Medtronic recently announced FDA approval of its MiniMed 530G low-glucose-suspend insulin pump, the first system approved in the U.S. that can automatically stop insulin delivery when blood glucose levels fall to a pre-set level.
News Briefs: Medtronic’s First-Gen Artificial Pancreas Approved; CMS Removes Bariatric Surgery Requirements
FDA approves Medtronic’s MiniMed 530G system, making it the first system in the U.S. that can automatically suspend insulin delivery to people with diabetes. CMS removes bariatric surgery facility certification requirements. More news.
FDA Audit Slows Down Medtronic Launch Plans For Low-Glucose-Suspend Diabetes System
A recent FDA inspection of Medtronic’s diabetes business identified quality systems deficiencies that are likely to delay the firm’s launch of its first-of-a-kind MiniMed 530G insulin pump/continuous glucose monitoring system.